.
MergerLinks Header Logo

New Deal


Announced

Completed

Prosus Ventures and TPG Growth led a $350m Series E funding round in PharmEasy.

Financials

Edit Data
Transaction Value£253m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Acquisition

Software

Venture Capital

pharmacy app

Minority

Friendly

Private

Completed

India

Cross Border

Private Equity

Single Bidder

Synopsis

Edit

Prosus Ventures, a venture capital firm, and TPG Growth, a private equity investment firm, led a $350m Series E funding round in PharmEasy, an Indian online pharmacy app. Additional investors include Temasek, CDPQ, LGT Lightrock, Eight Roads and Think Investments. “I am particularly proud that we have been able to not only provide consumers with much faster and easier access to the healthcare products and services they need but that we have been able to do so by empowering and digitizing 60k small pharmacy stores that provide such an essential service to the Indian public. Finding a solution that means we can work together, and all parties can benefit from the improvements in the system continues to be a driving force for the entire team," Siddharth Shah, API Holdings Co-Founder and CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US